DERM stock · J stock

DERM vs J · rev $56.1M vs P/E 36, $14.40B cap

Journey Medical Corp (DERM) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.

Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.

Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.

Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.

J does not have a complete income-statement cache yet.

DERM currently screens at market cap $163.1M. J currently screens at market cap $14.40B and trailing P/E 36.0.

Not investment advice. Open the DERM and J stock pages for the full models.

Not investment advice.

Popular Stock Comparisons